NCT07516353
- Conditions
- ALL, AML, Acute Lymphoblastic Leukemia ,Lymphomas, +32 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
ALL
Explore clinical trials studying ALL. Study availability and eligibility vary by location and protocol.
38 public trials
10 recruiting studies
ALL trial results
NCT02315612
- Conditions
- ALL, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, +32 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT06244147
- Conditions
- ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- SF Research Institute San Francisco, California, United States
NCT04473911
- Conditions
- ALL, AML, Acute Lymphoblastic Leukemia, +37 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT03114553
- Conditions
- ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- National Heart Centre of Singapore Singapore
NCT03275636
- Conditions
- ALL, AML, MDS
- Locations
-
- Universitätsklinikum Bonn Bonn, Germany
- Universitätsklinikum Dresden Dresden, Germany
- Universitätsklinikum Frankfurt Frankfurt am Main, Germany
- Universitätsklinikum Halle (Saale) Halle, Germany
Completed
Prediction of Excretion and Toxicity of High Dose Methotrexate in Children and Adolescents With ALL
NCT02133599
- Conditions
- ALL
- Locations
-
- Ann & Robert H. Lurie Children's Hosptial of Chicago Chicago, Illinois, United States
Completed
Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma
NCT01593696
- Conditions
- ALL, B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +16 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT00013533
- Conditions
- ALL, AML, Bone Marrow Diseases, +21 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Completed
Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT
NCT01012492
- Conditions
- ALL, AML, Anemia, +18 more
- Locations
-
- Boston Children's Hospital Boston, Massachusetts, United States